Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status-Reference-Cited by-同舟云学术

Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Published:2020-09-18 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Beeraka Narasimha M.,Sadhu Surya P.,Madhunapantula SubbaRao V.,Rao Pragada Rajeswara,Svistunov Andrey A.,Nikolenko Vladimir N.,Mikhaleva Liudmila M.,Aliev Gjumrakch

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference222 articles.

1. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China;Guan;Science.,2003

2. Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques;Haagmans;Nat Med.,2004

3. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus;Weiss;Microbiol Mol Biol Rev.,2005

4. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan;Chan;Emerg Microbes Infect.,2020

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon-induced transmembrane protein-1 competitively blocks Ephrin receptor A2-mediated Epstein–Barr virus entry into epithelial cells;Nature Microbiology;2024-04-22

2. Comparison of DASH diet score and total antioxidant capacity of diet on serum levels of TMPRSS‐2, inflammatory biomarkers, and disease severity in COVID‐19 patients: A case–control study;Food Science & Nutrition;2024-02-14

3. Effect of computationally designed fragment-based analogs on the RBD–ACE2 complex of the SARS-CoV-2 P.1 variant;Molecular Systems Design & Engineering;2024

4. Comparative Pharmacological Efficacy of COVID-19 Vaccines against the Variants of Concerns (VOCs) of SARS-CoV-2: Recent Clinical Studies on Booster Dose;Current Pharmaceutical Biotechnology;2023-11

5. Discovery of raffinose sulfate as a potential SARS CoV-2 inhibitor via blocking its binding with angiotensin converting enzyme 2;International Journal of Biological Macromolecules;2023-09